JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 52
- -2-3.70%
20min DelayTrading Nov 22 10:32 JST
4.36BMarket Cap-2855P/E (Static)
54High52Low946.80KVolume54Open54Pre Close49.90MTurnover10052wk High1.21%Turnover Ratio83.79MShares4152wk Low-16.51EPS TTM4.07BFloat Cap2229Historical HighLossP/E (Static)78.32MShs Float41Historical Low-18.21EPS LYR3.70%Amplitude--Dividend TTM3.59P/B100Lot Size--Div YieldTTM
BrightPath Biotherapeutics Key Stats
EPS
According to the latest financial report of BrightPath Biotherapeutics, the latest earnings per share (TTM) for the company is -3.07. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about BrightPath Biotherapeutics's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BrightPath Biotherapeutics shows that the company's current ratio is 4.14, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BrightPath Biotherapeutics, the quick ratio is 3.87, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of BrightPath Biotherapeutics? The latest ROE figure is -24.47%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BrightPath Biotherapeutics, the total asset return on investment (ROA) is -16.12%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BrightPath Biotherapeutics's latest financial report to see how their gross margin is doing - currently at 80.00%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BrightPath Biotherapeutics, the net profit margin is -4.29M%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data